80
Participants
Start Date
November 10, 2024
Primary Completion Date
September 30, 2028
Study Completion Date
September 30, 2028
vamorolone 40 mg/mL oral suspension
Vamorolone is administered at a dose range between 2 mg/kg/day and 6 mg/kg/day for boys weighing \<40 kg. For boys weighing 40 kg or above, the dose range will be 80 mg to 240 mg once daily. Doses can be adjusted within the dose range as determined by the Investigator based on tolerability. The highest tolerated dose should be used.
NOT_YET_RECRUITING
UZ Leuven (Universitair Ziekenhuis Leuven), Leuven
NOT_YET_RECRUITING
UZ Gent (Universitair Ziekenhuis Gent), Ghent
NOT_YET_RECRUITING
Hospital Universitario Puerta de Hierro Majadahonda, Madrid
NOT_YET_RECRUITING
Hospital Universitario y Politecnico de La Fe, Valencia
NOT_YET_RECRUITING
University Hospital Brno, Brno
RECRUITING
Fakultni Nemocnice Motol, Prague
NOT_YET_RECRUITING
Queen Elizabeth University Hospital, Glasgow
NOT_YET_RECRUITING
Alder Hey Children's Hospital, Liverpool
NOT_YET_RECRUITING
Leeds Teaching Hospitals NHS Trust, Leeds
NOT_YET_RECRUITING
University Hospitals Birmingham NHS Foundation Trust, Birmingham
NOT_YET_RECRUITING
Great Ormond Street Hospital for Children NHS Foundation Trust, London
NOT_YET_RECRUITING
The John Walton Muscular Dystrophy Research Centre, Newcastle
Lead Sponsor
Santhera Pharmaceuticals
INDUSTRY